Theravance Biopharma, Inc.
TBPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583107
In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Theravance Biopharma, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 121 | 2 | 113 | −6 |
| Shares | 63.0M | 83.5K | 64.2M | +1.31M (+2.1%) |
| Value | $602.5M | $798.0K | $582.0M | −$19.7M (−3.3%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Theravance Biopharma, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of Montreal | 217,527 | $1.95M | 0.00% |
| Victory Capital Management Inc | 63,650 | $577.0K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 34,794 | $315.0K | 0.00% |
| Squarepoint Ops LLC | 18,985 | $172.0K | 0.00% |
| SG Americas Securities, LLC | 17,698 | $160.0K | 0.00% |
| Walleye Trading LLC | 14,475 | $131.0K | 0.00% |
| Quantbot Technologies LP | 6,905 | $62.0K | 0.01% |
| State of Wyoming | 4,275 | $39.0K | 0.02% |
| Crewe Advisors LLC | 131 | $1.00K | 0.00% |
Sold out (15)
Institutions that held Theravance Biopharma, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Two Sigma Investments, LP | 149,240 | $1.43M |
| CM Management, LLC | 120,000 | $1.15M |
| ExodusPoint Capital Management, LP | 53,850 | $515.0K |
| Connor, Clark & Lunn Investment Management Ltd. | 40,477 | $387.0K |
| Caption Management, LLC | 31,800 | $304.0K |
| Campbell & CO Investment Adviser LLC | 25,100 | $240.0K |
| SG3 Management, LLC | 24,800 | $237.0K |
| Bank of Nova Scotia | 21,652 | $207.0K |
| Millennium Management LLC | 17,805 | $170.0K |
| Rafferty Asset Management, LLC | 12,707 | $121.0K |
| Diversified Trust Co | 12,122 | $116.0K |
| Teacher Retirement System of Texas | 11,525 | $110.0K |
| Two Sigma Advisers, LP | 10,700 | $102.0K |
| Acadian Asset Management LLC | 8,277 | $77.0K |
| Allworth Financial LP | 1,130 | $11.0K |
Not filed for Q2 2022 yet (2)
Institutions that held Theravance Biopharma, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 73,983 | $707.0K |
| Amalgamated Financial Corp. | 9,556 | $91.0K |